Header Logo

John Stock

Concepts (80)

Back to Profile
Concepts are derived automatically from a person's publications.
Concepts are listed by decreasing relevance which is based on many factors, including how many publications the person wrote about that topic, how long ago those publications were written, and how many publications other people have written on that same topic.


Name Number of Publications Most Recent Publication Publications by All Authors Concept Score Why?
Raloxifene Hydrochloride
12
2013
18
1.730
 Why?
Osteoporosis, Postmenopausal
12
2013
48
1.510
 Why?
Bone Density Conservation Agents
6
2013
46
1.000
 Why?
Selective Estrogen Receptor Modulators
8
2010
17
0.770
 Why?
Fractures, Bone
7
2010
142
0.750
 Why?
Alendronate
5
2013
14
0.730
 Why?
Spinal Fractures
5
2008
37
0.590
 Why?
Bone Density
8
2013
134
0.430
 Why?
Osteoporosis
3
2008
108
0.330
 Why?
Cardiovascular Diseases
3
2008
832
0.240
 Why?
Breast Neoplasms
5
2013
1193
0.220
 Why?
Double-Blind Method
5
2008
739
0.190
 Why?
Estrogen Replacement Therapy
3
2006
80
0.170
 Why?
Femur Neck
3
2005
11
0.130
 Why?
Diphosphonates
3
2010
34
0.120
 Why?
Middle Aged
10
2013
17363
0.110
 Why?
Absorptiometry, Photon
2
2005
76
0.100
 Why?
Aged
10
2013
14254
0.100
 Why?
Osteoporotic Fractures
1
2013
33
0.100
 Why?
Female
14
2013
32488
0.100
 Why?
Treatment Outcome
5
2010
5590
0.090
 Why?
Thiophenes
1
2010
29
0.080
 Why?
Risk
3
2008
375
0.080
 Why?
Piperidines
1
2010
63
0.080
 Why?
Humans
16
2013
62678
0.080
 Why?
Mortality
1
2010
160
0.080
 Why?
Lumbar Vertebrae
3
2005
156
0.070
 Why?
Postmenopause
4
2010
236
0.070
 Why?
Safety
1
2006
144
0.060
 Why?
Calcitonin
2
2004
17
0.060
 Why?
Venous Thrombosis
1
2006
113
0.060
 Why?
Clinical Trials as Topic
1
2008
453
0.060
 Why?
Risk Reduction Behavior
1
2005
122
0.060
 Why?
Randomized Controlled Trials as Topic
3
2004
729
0.060
 Why?
Decision Support Techniques
1
2006
194
0.060
 Why?
Vitamin D
2
2004
139
0.060
 Why?
Bone and Bones
1
2005
142
0.050
 Why?
Cerebrovascular Disorders
1
2004
81
0.050
 Why?
Follow-Up Studies
2
2010
2445
0.050
 Why?
Hip Fractures
1
2004
77
0.050
 Why?
Estrogen Receptor Modulators
1
2002
8
0.050
 Why?
Calcium
2
2004
571
0.050
 Why?
Medical Records
1
2002
137
0.050
 Why?
Logistic Models
1
2004
1273
0.040
 Why?
Health Care Surveys
1
2002
285
0.040
 Why?
Aged, 80 and over
2
2010
5406
0.040
 Why?
Research Design
1
2002
572
0.040
 Why?
Placebos
2
2010
71
0.040
 Why?
Incidence
2
2008
1367
0.020
 Why?
Bone Resorption
1
2010
41
0.020
 Why?
Women's Health
1
2013
369
0.020
 Why?
Comorbidity
1
2013
1118
0.020
 Why?
Adult
1
2004
16625
0.020
 Why?
Cohort Studies
1
2013
2539
0.020
 Why?
Coronary Disease
1
2008
246
0.020
 Why?
Time Factors
2
2005
3742
0.020
 Why?
Femoral Neck Fractures
1
2005
10
0.020
 Why?
Poisson Distribution
1
2005
53
0.010
 Why?
United States
2
2013
7719
0.010
 Why?
Bone Remodeling
1
2005
25
0.010
 Why?
Fracture Healing
1
2005
27
0.010
 Why?
Cost-Benefit Analysis
1
2006
308
0.010
 Why?
Multicenter Studies as Topic
1
2004
137
0.010
 Why?
Age Distribution
1
2004
258
0.010
 Why?
Hormones
1
2004
60
0.010
 Why?
Population Surveillance
1
2004
203
0.010
 Why?
Estrogens
1
2004
115
0.010
 Why?
Proportional Hazards Models
1
2005
726
0.010
 Why?
Global Health
1
2004
182
0.010
 Why?
Risk Factors
2
2004
5302
0.010
 Why?
Disease Notification
1
2002
5
0.010
 Why?
Patient Selection
1
2004
482
0.010
 Why?
Reference Values
1
2002
335
0.010
 Why?
Guidelines as Topic
1
2002
156
0.010
 Why?
Mass Screening
1
2006
689
0.010
 Why?
Retrospective Studies
1
2013
6535
0.010
 Why?
Prevalence
1
2004
1348
0.010
 Why?
Biomarkers
1
2004
1385
0.010
 Why?
Prospective Studies
1
2004
3258
0.010
 Why?
Surveys and Questionnaires
1
2002
2648
0.010
 Why?
Stock's Networks
Click the
Explore
buttons for more information and interactive visualizations!
Concepts (80)
Explore
_
Similar People (60)
Explore
_
Same Department Expand Description
Explore
_
Physical Neighbors
_